Aepodia Having worked in internal clinical research for Eli Lilly for 14 years, from 1993 – 2007, what has this experience taught you about what pharmaceutical companies need in an outsourcing partner, and how does Aepodia respond to those needs? What we have seen is a transformation in the pharmaceutical industry.…
Mexican Diabetes Federation Could you give us a brief introduction to the Federacion Mexicana de Diabetes? The Mexican Diabetes Federation was established in 1988 by a group of people affected by diabetes, as well as families and health professionals interested in tackling this disease in a more effective and preventive way Nowadays our…
Zodiac Pharmaceuticals What would you recommend in terms of increasing the competitiveness and growth of the Brazilian pharmaceutical industry? The Brazilian pharmaceutical industry needs to improve its R&D capabilities. I personally think that the country can’t build a strong pharmaceutical industry based only on generics. Generics are an important part of the…
UCB India You have only recently been appointed Managing Director for the first time in your career. How did your first year with UCB India go so far? My first year at UCB has gone very well. Our business has grown in this period ahead of the Pharma market in India. My…
Novo Nordisk India Private Limited Novo Nordisk seems somewhat of an exception to the MNCs that recently entered India, as it already set up its HQ in Bangalore in 1994. How do you explain this relatively early entry? Traditionally, Novo Nordisk’s strategy has been to be in the market very early. We aspire to create…
PAREXEL India PAREXEL has had a long-term commitment to India. Could you give us a brief overview of your activities in the country? PAREXEL offers clinical development services throughout India. In 2004, PAREXEL entered into a joint alliance with Synchron then expanded our presence in India. In 2007, PAREXEL opened an office…
DSM India With almost EUR 9bn turnover and more than 22,000 people worldwide, Royal DSM has truly grown into an MNC. Within the global market, there is no doubt that India has become a country of rising opportunities… Can you first elaborate what DSM India represents to the Group worldwide? Every 5…
Dr Reddy's Laboratories Looking back at the company’s recent challenges, we see a very tough 2009, largely due to the Betapharm acquisition and the subsequent changes in German regulations. How do you explain the situation there and what measures did you take to turn the situation around? Germany, and in particular the Betapharm…
India Since the company’s foundation in 1993, Hetero has clearly come a long way. What were the key success factors at that time, which laid the groundwork of a successful company? First of all, I am a scientist by background, and before founding Hetero I had been working at Dr. Reddy’s…
India Dilip Surana of family-run Indian generics giant Micro Labs talks company performance, the evolution of the Indian pharma market, and strategy moving forward. Last year Micro Labs moved up in the rankings. How satisfied are you with the company’s performance in 2010? The company performed satisfactorily last year, showing good…
Eli Lilly and Company (India) Pvt. Ltd. Having been director here in India between 1998-2002, and then again since 2006, you have clearly been in the front seat to observe the evolution of the Indian market. How have you experienced the increasing presence of MNCs in India? Absolutely … A transformation has clearly taken place over the…
See our Cookie Privacy Policy Here
